– Investigator-initiated Phase 2 study is being conducted at Northwestern University in cooperation with Moleculin– Funding for study provided by NIH and BrainUp®– Trial combines WP1066 and radiation, which demonstrated both significant therapeutic response and immune memory in glioblastoma animal modelsHOUSTON, Sept. 9, 2024 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company), a Phase 3 clinical-stage pharmaceutical company with a broad portfolio of drug candidates targeti ...